Details for New Drug Application (NDA): 020156
✉ Email this page to a colleague
The generic ingredient in VIDEX is didanosine. There are eight drug master file entries for this compound. Additional details are available on the didanosine profile page.
Summary for 020156
Tradename: | VIDEX |
Applicant: | Bristol |
Ingredient: | didanosine |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 020156
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | FOR SOLUTION;ORAL | Strength | 10MG/ML | ||||
Approval Date: | Oct 9, 1991 | TE: | RLD: | Yes |
Expired US Patents for NDA 020156
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Bristol | VIDEX | didanosine | FOR SOLUTION;ORAL | 020156-001 | Oct 9, 1991 | ⤷ Sign Up | ⤷ Sign Up |
Bristol | VIDEX | didanosine | FOR SOLUTION;ORAL | 020156-001 | Oct 9, 1991 | ⤷ Sign Up | ⤷ Sign Up |
Bristol | VIDEX | didanosine | FOR SOLUTION;ORAL | 020156-001 | Oct 9, 1991 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription